
The inhibition of NLRP3 signaling attenuates liver injury in an α-galactosylceramide-induced hepatitis model
Keywords: آلفا گالاکتوسیلسرامید; Immune-mediated liver injury; Inflammasomes; NLRP3; Alpha-galactosylceramide;